pioglitazone
美 
英
- 網(wǎng)絡(luò)吡格列酮；匹格列酮；皮利酮
例句
Compared with rats that received sham irradiation, irradiated rats that did not receive pioglitazone displayed cognitive impairment.
和虛假放射的小鼠相比，未服藥的放射鼠出現(xiàn)認知缺損。
We did not observe similar associations in a secondary analysis evaluating pioglitazone.
我們在第二次羅格列酮分析評估中沒有看到類似的相關(guān)性。
"The PROACTIVE data went in the right direction, so I would say pioglitazone was probably safe, " he said.
在正確的方向顯示積極的數(shù)據(jù)，所以我要說匹格列酮類藥物可能是安全的。
The other is combine pioglitazone with vitamin E compare to vitamin E alone to see how these drugs work in the long term.
另一項研究將吡格列酮聯(lián)合維生素E治療與維生素E單藥治療的長期效果進行了比較。
Rosiglitazone and pioglitazone are part of a group of drugs called thiazolidinediones.
羅格列酮和吡咯列酮同屬噻唑烷二酮類。
Like insulin and other diabetes drugs, rosiglitazone and a similar drug, pioglitazone (Actos), lower blood sugar.
像胰島素和其他降糖藥物一樣，文迪亞與一種與其相似的藥物比格列酮一樣，具有降血糖的作用。
Pioglitazone clearly has fallen on the side of cardiovascular benefits or very close.
吡格列酮明顯傾向于心血管獲益方面或者非常接近。
International Diabetes: Do rosiglitazone and pioglitazone have different or similar properties in respect to their cardiovascular profiles?
《國際糖尿病》：羅格列酮和吡格列酮對心血管的影響是否有所差別？二者有何相似性？
Has some of the bad press and issues with rosiglitazone unfairly affected pioglitazone?
有關(guān)羅格列酮的一些負面新聞是否會對吡格列酮有影響？
In addition, Actos (pioglitazone), a drug used to treat diabetes, also improved many features of NASH but was associated with weight gain.
另外，一種用于治療糖尿病的藥物Actos（匹格列酮）也可改善NASH的很多癥狀，但會導(dǎo)致肥胖。
Objective To observe the effects of pioglitazone on stent restenosis in coronary heart disease patients with impaired glucose tolerance.
目的觀察吡格列酮對冠心病合并糖耐量異常患者冠脈支架內(nèi)再狹窄的影響。
International Diabetes: Does pioglitazone have more favorable effects on serum lipids than rosiglitazone?
《國際糖尿病》：吡格列酮對血脂的作用是否優(yōu)于羅格列酮？
By contrast, no drop in cognitive function was observed in irradiated animals treated with pioglitazone.
但是，服藥放射鼠的認知能力卻沒有下降。
No difference between rosiglitazone and pioglitazone was apparent.
羅格列酮和匹格列酮間無明顯差別。
It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.
它的部分經(jīng)費由吡格列酮的制造商武田制藥提供。
Pioglitazone was tested in combination with a sulfonylurea, insulin, or metformin in 8 trials (8501 patients).
吡格列酮聯(lián)用磺脲類、胰島素或者二甲雙胍用于8項試驗（8501個病人）。
Effects of combined treatment with glimepiride and pioglitazone on metabolic syndrome patients with type 2 diabetes mellitus.
格列美脲和吡格列酮聯(lián)合治療代謝綜合征合并2型糖尿病臨床觀察。
Beginning in 1999, rosiglitazone maleate and pioglitazone hydrochloride were approved for use.
從1999年開始，馬來酸羅格列酮和鹽酸匹格列酮被批準使用。
Objective To explore the effects of Pioglitazone in Treatment of non-alcoholic fatty liver disease with type 2 diabetes mellitus.
目的探討吡格列酮對2型糖尿病合并非酒精性脂肪肝病的臨床效果。
Certainly, in heart failure it has cardiovascular mortality which was not seen with the pioglitazone heart failure group.
當(dāng)然，在心力衰竭方面，心衰組患者沒有發(fā)現(xiàn)心血管疾病的死亡率與吡格列酮相關(guān)。
Patients taking pioglitazone averaged 380 days of medication, and patients taking rosiglitazone averaged 369 days of medication.
服用匹格列酮的病人平均進行了380天的治療，服用羅格列酮的病人平均進行了369天的治療。
Pioglitazone and metformin have both proven safe and efficacious in the treatment of type 2 diabetes.
吡格列酮和二甲雙胍都證明安全有效的治療2型糖尿病。
TABLE 2 lists the clinical outcome measures in the pioglitazone and control groups of the 19 individual trials.
表2列舉了吡格列酮及對照組共19項試驗的臨床結(jié)果。
Insulin sensitivity in the liver improved by 48 percent in the pioglitazone group, compared to 14 percent in the placebo group.
與安慰劑組的14%相比，服用吡格列酮組肝臟的胰島素敏感型改善了48%。
I would choose in this order metformin, pioglitazone, GLP-1 compound and then insulin.
我會按照這樣的順序選擇，二甲雙胍，吡格列酮，GLP-1類藥物，然后才是胰島素。
When you look at the composite meta-analysis data for pioglitazone, it falls on the good side.
當(dāng)你觀察吡格列酮復(fù)合的薈萃分析數(shù)據(jù)，它傾向于好的方面。
My personal view is that pioglitazone should stay on the market and just be used a little more carefully.
我個人的觀點是吡格列酮應(yīng)當(dāng)在市場上保留，只用應(yīng)用時多點兒謹慎。
Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy
有限采樣法估算口服吡格列酮制劑的生物等效性
Studies on the Dissolution Rates of Pioglitazone Hydrochloride Tablets Preparation from Different Manufactures
不同廠家鹽酸吡格列酮片的溶出度考察
Research to manufacture the Pioglitazone Hydrochloride orally disintegrating tablets
鹽酸吡格列酮口腔崩解片的研制
Determination of Organic Residual Solvents in Pioglitazone Hydrochloride by Capillary Gas Chromatography
毛細管氣相色譜法測定鹽酸吡格列酮中有機溶劑殘留量
Effects of pioglitazone on expression of myocardial proinflammatory cytokine in left ventricular hypertrophic rats
吡格列酮對左心室肥厚大鼠心肌炎性細胞因子表達的影響
Simultaneous determination of pioglitazone and its two active metabolites in human plasma by HPLC-MS
HPLC-MS同時測定人血漿中吡格列酮及其活性代謝產(chǎn)物的濃度
Effects of pioglitazone and irbesartan on vascular smooth muscle cells proliferation induced by advanced glycation end products
吡格列酮和厄貝沙坦對糖基化終產(chǎn)物誘導(dǎo)血管平滑肌細胞增殖的影響
Pioglitazone on fibrinolytic system in elderly hypertensive patients with insulin resistance
吡格列酮對老年高血壓并胰島素抵抗病人纖溶系統(tǒng)的影響
Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mice
吡格列酮對非肥胖性糖尿病小鼠糖尿病的預(yù)防作用及機理探討
Effects of different dosages of pioglitazone hydrochloride on insulin sensitivity of patients with diabetes
不同劑量鹽酸吡格列酮對胰島素敏感性的影響
Antiproliferative effects of pioglitazone involved of nitric oxide on cultured rabbit aortic smooth muscle cells
一氧化氮部分介導(dǎo)吡格列酮抑制培養(yǎng)兔胸主動脈平滑肌細胞增殖
Pharmacokinetics of pioglitazone hydrochloride tablets in healthy human subjects after a single dose administration
單劑口服鹽酸吡格列酮片在健康人體的藥代動力學(xué)
Graphical Synthetic Routes of Pioglitazone Hydrochloride
鹽酸吡格列酮合成路線圖解
